The effect of oral protease administration in the rat remnant kidney model

Research in Experimental Medicine

Volumn 199, Issue 3, 1999, Pages 177-188

  Šebeková, Katarína ^a   Dämmrich, Jobst ^c   Krivošíková, Zora ^a   Heidland, August ^b  

^a INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c NONE

Author keywords

Proteases; Proteinuria; Rat remnant kidney model; Renal fibrosis; TGF 1

Indexed keywords

CREATININE; CYTOKINE; PHLOGENZYM; PROTEINASE; TRANSFORMING GROWTH FACTOR BETA1; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME THERAPY; GLOMERULUS; INTERSTITIUM; KIDNEY CORTEX; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY TUBULE; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; TIME; UREA BLOOD LEVEL; URINARY EXCRETION;

EID: 0033371339     PISSN: 03009130     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004330050122     Document Type: Article

References (36)

1. 1. Abbate M, Zoja C, Corna D, Capitanio M, Bertani T, Remuzzi G (1998) In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation. J Am Soc Nephrol 9: 1213-1224
2. 2. Anderson S, Meyer TW, Rennke HG, Brenner BM (1985) Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76: 612-619
3. 3. Baricos WH (1994) Decreased proteolysis of the glomerular extracellular matrix as a pathogenetic mechanism in progressive renal disease. J Nephrol 7: 322-328
4. 4. Castell JV, Friedrich G, Kuhn CS, Poppe GE (1997) Intestinal absorption of undegraded proteins in men: presence of bromelain in plasma after oral intake. Am J Physiol 273: 139-146
5. 5. Bader R, Bader H, Grand KE, Mackensen-Haen S, Christ H, Bohle A (1980) Structure and function of the kidney in diabetic glomerulosclerosis: correlations between morphological and functional parameters. Pathol Res Pract 167: 204-216
6. 2-macroglobulin. J Biol Chem 264: 5818-5825
7. 2-macroglobulin, a multifunctional binding protein with targeting characteristics. FASEB J 6: 3345-3353
8. 8. Megel H, Strauss R, Ho R, Beiler M (1964) Detection of trypsin-like-activity in the plasma of rats after oral administration of trypsin. Arch Biochem Biophys 108: 193-199
9. 9. Ellis D, Forrest K-YZ, Erby J, Orchard TJ (1998) Urinary measurement of transforming growth factor β and type IV collagen as new markers of renal injury: application in diabetic nephropathy. Clin Chem 44: 950-956
10. 10. Gesualdo L, Ricanti S, Hassan MO, Emancipator SN, Lamm ME (1990) Enzymolysis of glomerular immune deposits in vivo with dextranase/protease ameliorates proteinuria, hematuria and mesangial proliferation in murine experimental IgA nephropathy. J Clin Invest 86: 715-722
11. 11. Gilbert R, Wu L, Cox A, Roe C, Dziadek M, Cooper ME (1995) TGF-β and SPARC are increased in subtotal nephrectomy. J Am Soc Nephrol 6: 1332 A
12. 12. Gretz N, Waldherr R, Strauch M (1993) The remnant kidney model. In: Gretz N, Strauch M (eds) Experimental and genetic rat models of chronic renal failure. Karger, Basel, pp 1-28
13. 13. Harrach T, Gebauer F, Eckert K, Kunze R, Mauer HR (1989) Bromelain proteinases modulate the CD44 expression on Molt 4/8 leukemia and SK-Mel 28 melanoma cells in vitro. Int J Oncol 5: 485-488
14. 14. Heidland A, Ling H, Vamvakas S, Paczek L (1996) Impaired proteolytic activity as a potential cause of progressive renal disease. Miner Electrolyte Metab 22: 157-161
15. 15. Honkanen E, Teppo AM, Törnroth T, Grönhagen-Riska C (1995) Urinary transforming growth factor β1 (TGF-β1) and progression of glomerular disease. J Am Soc Nephrol 6: 108 A
16. 2-macroglobulin. Immunol Today 11: 163-166
17. 17. Jones CL, Forbes JM, Walker RG, Becker GJ (1996) Activation of renal type IV collagenases. J Am Soc Nephrol 7: S1756
18. 18. Kolac C, Streichhan P, Lehr CM (1996) Oral bioavailability of proteolytic enzymes. Eur J Pharm Biopharm 42: 222-232
19. 19. Labarca C, Peigen K (1979) A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102: 344-352
20. 20. Lehmann PV (1996) Immunomodulation by proteolytic enzymes. Nephrol Dial Transplant 11: 953-955
21. 21. Lovett DH, Sterzel RB, Kashgarian M, Ryan JL (1983) Neutral proteinase activities produced in vitro by cells of the glomerular mesangium. Kidney Int 23: 342-349
22. 22. Morrison AB (1962) Experimentally induced chronic renal insufficiency in the rat. Lab Invest 11: 321-332
23. 23. Targoni OS, Tary-Lehmann M, Lehmann PV (1999) Prevention of murine EAE by oral hydrolytic enzyme treatment. J Autoimmunity 12: 191-198
24. 24. Gaciong Z, Paczek L, Bojakowski K, Wisniewski M, Heidland A (1996) Beneficial effects of proteases on allograft arteriosclerosis in a rat aortic model. Nephrol Dial Transplant 11: 987-989
25. 25. Remuzzi G, Ruggenenti P, Benigni A (1997) Understanding the nature of renal disease progression. Kidney Int 51: 2-15
26. 26. Schaefer L, Lorenz T, Dämmrich J, Heidland A, Schäfer RM (1995) Role of proteinases in renal hypertrophy and matrix accumulation. Nephrol Dial Transplant 10: 801-807
27. 27. Šebeková K, Dämmrich J, Fierlbeck W, Krivošíková Z, Paczek L, Heidland A (1997) Systemic treatment with proteolytic enzymes in rat models of nonimmune mediated renal diseases. Int J Immunotherapy 3/4: 79-83
28. 28. Šebeková K, Paczek L, Dämmrich J, Ling H, Spustová V, Gaciong Z, Heidland A (1997) Effects of protease therapy in the remnant kidney model of progressive renal failure. Miner Electrolyte Metab 23: 291-295
29. 29. Smith PK, Krohn RJ, Hermanson GT, Mallia AK, Garter FH, Provenzano M, Fujimoto EK, Goecke NM, Olson BJ, Klenk DC (1985) Measurement of protein using bicinochoninic acid. Anal Biochem 50: 76-85
30. 30. Spiro RG (1984) Studies on the renal glomerular basement membrane: preparation and chemical composition. J Biol Chem 242: 1915-1919
31. 31. Teschner M, Schäfer RM, Paczek L, Heidland A (1992) Effect of renal disease on glomerular proteinases. Miner Electrolyte Metab 18: 92-98
32. 32. Trottier G, Saifeddine M, Hollenberg M, Loutzenhiser R (1998) Proteinase A activated receptor 2 (PAR2) peptide evokes nitric-oxide dependent vasodilation in the renal microcirculation. J Am Soc Nephrol 9: 408A
33. 33. White RB, Lowrie L, Stork JE, Iskander SS, Lamm ME, Emancipator SN (1991) Target enzyme treatment in experimental glomerulonephritis in rats. J Clin Invest 87: 1819-1827
34. 34. Williams GR, Harrison TR, Grollmann A (1939) A simple method for determining the systolic blood pressure in unanesthesized rats. J Clin Invest 18: 373-383
35. 35. Yamamoto T, Noble NA, Miller DE, Border WA (1994) Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int 45: 916-927
36. 36. Ylitalo P, Hepp R, Oster P, Möhring J, Gross F (1976) Effects of various sodium intake on blood pressure protein/DNA ratio in isolated and renin-angiotensin system in subtotally nephrectomized rats. J Lab Clin Med 88: 807-816